Cytochrome P450 4F2 antibody [N2C2], Internal
GTX102722
ApplicationsWestern Blot
Product group Antibodies
TargetCYP4F2
Overview
- SupplierGeneTex
- Product NameCytochrome P450 4F2 antibody [N2C2], Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.28 mg/ml
- ConjugateUnconjugated
- Gene ID8529
- Target nameCYP4F2
- Target descriptioncytochrome P450 family 4 subfamily F member 2
- Target synonymsCPF2, cytochrome P450 4F2, 20-HETE synthase, 20-hydroxyeicosatetraenoic acid synthase, CYPIVF2, arachidonic acid omega-hydroxylase, cytochrome P450, family 4, subfamily F, polypeptide 2, cytochrome P450, subfamily IVF, polypeptide 2, cytochrome P450-LTB-omega, docosahexaenoic acid omega-hydroxylase, leukotriene-B(4) 20-monooxygenase 1, leukotriene-B(4) omega-hydroxylase 1, phylloquinone omega-hydroxylase CYP4F2
- HostRabbit
- IsotypeIgG
- Protein IDP78329
- Protein NameCytochrome P450 4F2
- Scientific DescriptionThis gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Podszun MC, Grebenstein N, Hofmann U, et al. High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs. Toxicol Appl Pharmacol. 2013,266(3):452-8. doi: 10.1016/j.taap.2012.11.018Read this paper




